Keywords: Nordic Pharma, Nippon Kayaku, Spanidin, Wegener's granulomaaaatosis

Nordic Pharma Group gets ex-Japan rights to Nippon Kayaku’s on Spanidin

Article | 24 December 2010

Privately-held France-headquartered Nordic Pharma Group (Nordic) has signed a licensing agreement for exclusive rights to development and commercialize Japanese firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Nippon Kayaku

Nordic Pharma

Go to company listing

Related Drugs

Spanidin

Go to drug listing